logo-loader
viewAdmedus Ltd

Admedus appoints Catherine Costello as interim executive director

The company has filed three new provisional patent applications in the US.

table and chairs
Costello is also the chief financial officer

Admedus Ltd (ASX:AHZ) has appointed Catherine Costello to the board as interim executive director.

Costello also holds the dual positions of company secretary and chief financial officer.

Her appointment as executive director follows the resignation of Mathew Ratty and fulfils the requirement to have two resident Australian directors.

Admedus has commenced the search for another permanent Australian resident director to replace Ratty.

READ: Admedus files three new patents in the US for heart valve device

The company has filed three new provisional patent applications in the US as part of its transcatheter aortic valve replacement (TAVR) research and development project.

TAVR is where a valve is placed into the heart via a catheter (usually inserted through the leg) to replace the aortic valve, eliminating the need for open-heart surgery.

Admedus’ new TAVR device is designed to reduce the risks associated with the insertion and placement of the valve.

READ: Admedus progressing to animal trials of its unique heart valve device

Quick facts: Admedus Ltd

Price: 0.085 AUD

ASX:AHZ
Market: ASX
Market Cap: $50.22 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Admedus Ltd named herein, including the promotion by the Company of Admedus Ltd in any Content on the Site, the Company receives from said...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Admedus CEO in New York to update on recent key milestones

Admedus Ltd (ASX:AHZ) CEO Wayne Paterson visited the Proactive Investors New York studio to update on key milestones the company has achieved in the past few months, including receiving European approval on two of its products.

on 03/17/2019

2 min read